To hear about similar clinical trials, please enter your email below
Trial Title:
The Effect of the Association EGCG, Folic Acid and Vitamin B12 in Preventing the Persistence of HPV Infection.
NCT ID:
NCT06285357
Condition:
HPV Infection
Conditions: Official terms:
Infections
Communicable Diseases
Papillomavirus Infections
Folic Acid
Study type:
Interventional
Study phase:
N/A
Overall status:
Recruiting
Study design:
Allocation:
Randomized
Intervention model:
Parallel Assignment
Primary purpose:
Treatment
Masking:
None (Open Label)
Intervention:
Intervention type:
Dietary Supplement
Intervention name:
EGCG + folic acid + B12
Description:
EGCG + folic acid + B12
Arm group label:
treatment
Summary:
The purpose of the study is to test the effect of the administration of a dietary
supplement consisting of epigallocatechin gallate (EGCG), vitamin B12 and folic acid in
the treatment of infections with papilloma virus of the cervix.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- HR-HPV DNA test positivity
Exclusion Criteria:
- No HSIL
Gender:
Female
Minimum age:
25 Years
Maximum age:
65 Years
Healthy volunteers:
No
Locations:
Facility:
Name:
Azienda Ospedaliero-Universitaria di Modena
Address:
City:
Modena
Zip:
41124
Country:
Italy
Status:
Recruiting
Contact:
Last name:
Giovanni Grandi
Start date:
February 19, 2024
Completion date:
December 2025
Lead sponsor:
Agency:
Lo.Li.Pharma s.r.l
Agency class:
Industry
Source:
Lo.Li.Pharma s.r.l
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06285357
